New York · 2025 Regular Session · Bill
S 9322: Relates to adding 7-Hydroxymitragynine to the schedule of controlled substances
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 9322 is a bill introduced in the New York Senate on February 27, 2026. According to its official title, it concerns: Relates to adding 7-Hydroxymitragynine to the schedule of controlled substances. Primary sponsor: Tony Palumbo (Republican). Most recent recorded action (February 27, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Adds 7-Hydroxymitragynine, including its salts, isomers and salts of isomers, as a schedule 1 controlled substance.
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Tony Palumbo | Primary sponsor | Republican | Senate | 1 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH